Latest in Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals
Sort by
5,677 items
-
Rocket Lab stock surges almost 30% to near all-time high after company's Q3 results
Rocket Lab jumped in trading after the company reported third-quarter results.Business - CNBC - November 13 -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.Business - CNBC - November 13